Skip to main content
Fig. 5 | BMC Cardiovascular Disorders

Fig. 5

From: Salvianolic acid a inhibits platelet activation and aggregation in patients with type 2 diabetes mellitus

Fig. 5

Impacts of Salvianolic acid A (SAA) on single-platelet activation. Platelet-rich plasma (PRP) was preincubated with a vehicle or SAA (0.1 mg/ml, 22 °C, 10 min) in the presence of the fluorescent PAC-1 or CD62p antibodies. Samples were then stimulated by ADP (20 μM) or thrombin (0.2 U/ml) and incubated for 15 min. The PAC-1 (a, b) and CD62p (c, d) of single platelets were monitored by flow cytometry

Back to article page